Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED BALANCE SHEETS

v3.24.0.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
ASSETS    
Available-for-sale securities, at fair value (amortized cost $8,509,383 and $8,114,627, respectively; allowance for credit losses $3,943 and $6,958, respectively) $ 8,327,149 $ 7,778,734
Mortgage servicing rights, at fair value 3,052,016 2,984,937
Cash and cash equivalents 729,732 683,479
Restricted cash 65,101 443,026
Accrued interest receivable 35,339 36,018
Due from counterparties 323,224 253,374
Derivative assets, at fair value 85,291 26,438
Reverse repurchase agreements 284,091 1,066,935
Other assets 236,857 193,219
Total Assets 13,138,800 13,466,160
Liabilities    
Repurchase agreements 8,020,207 8,603,011
Revolving credit facilities 1,329,171 1,118,831
Term notes payable 295,271 398,011
Convertible senior notes 268,582 282,496
Derivative liabilities, at fair value 21,506 34,048
Due to counterparties 574,735 541,709
Dividends payable 58,731 64,504
Accrued interest payable 141,773 94,034
Commitments and contingencies (see Note 16) 0 0
Other liabilities 225,434 145,991
Total Liabilities 10,935,410 11,282,635
Stockholders' Equity    
Preferred stock, par value $0.01 per share; 100,000,000 shares authorized and 25,356,426 and 26,092,050 shares issued and outstanding, respectively ($633,911 and $652,301 liquidation preference, respectively) 613,213 630,999
Common stock, par value $0.01 per share; 175,000,000 shares authorized and 103,206,457 and 86,428,845 shares issued and outstanding, respectively 1,032 864
Additional paid-in capital 5,925,424 5,645,998
Accumulated other comprehensive loss (176,429) (278,711)
Cumulative earnings 1,349,973 1,453,371
Cumulative distributions to stockholders (5,509,823) (5,268,996)
Total Stockholders’ Equity 2,203,390 2,183,525
Total Liabilities and Stockholders’ Equity $ 13,138,800 $ 13,466,160